SMITH SCOTT THOMAS

PrivateCIK: 1965550
Location

HELLERUP, G7

SMITH SCOTT THOMAS enters ASCENDIS PHARMA A/S with 2.52K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderSMITH SCOTT THOMASCIK 1965550
IssuerASCENDIS PHARMA A/SCIK 1612042
Officer· EVP & Chief Financial Officer
Since Mar 2026
2.52K
Baseline shares
100% direct
2.52K
Direct ownership
1 position
171.25K
Derivative underlying
8 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Ordinary Shares

Direct
Shares owned2.52K
Total
2.52K direct2.52K
Derivative Holdings8

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

45K

Shares owned

N/A

Exercise price

37.18

Expiration

Exercise window

Restricted Stock Units

Direct
Underlying security
Ordinary Shares

Underlying shares

3.20K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

45K

Shares owned

N/A

Exercise price

62.17

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

27K

Shares owned

N/A

Exercise price

108

Expiration

Exercise window

Restricted Stock Units

Direct
Underlying security
Ordinary Shares

Underlying shares

4.25K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Restricted Stock Units

Direct
Underlying security
Ordinary Shares

Underlying shares

9.55K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

22.75K

Shares owned

N/A

Exercise price

176.28

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

14.50K

Shares owned

N/A

Exercise price

139.65

Expiration

Exercise window

Total

Underlying

171.25K

Owned

0.00

SMITH SCOTT THOMAS — Initial Ownership Disclosure (Form 3) Filed Mar 18, 2026 | Finecho